Laguna Recaps Key Milestones, Drivers to Corporate Growth Strategy

- July 18th, 2016

KELOWNA, BC – July 18, 2016 – Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) (the “Company” or “Laguna”), a network marketing company, today highlights recent milestones complementary to its overall growth strategy and planned entrance into the $121 billion global skin care industry.

KELOWNA, BC – July 18, 2016 – Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) (the “Company” or “Laguna”), a network marketing company, today highlights recent milestones complementary to its overall growth strategy and planned entrance into the $121 billion global skin care industry.

Most recently and as previously announced, Laguna signed a non-binding letter of intent to acquire the exclusive license brand name and existing inventory of CannaCeuticals of California, USA (“Canna”), a Swiss heritage company utilizing cosmeceutical-grade cannabidiol (CBD) for its line of revolutionary skincare products. Upon closing of the transaction, Laguna Blends will leverage its expanding affiliate marketing network to sell Canna products in North America. Per the agreement, Laguna will also receive license and marketing rights to sell Canna products in Asia, Europe and Mexico, subject to regulatory approval in those markets.

In a recent clinical trial of the efficacy of Canna’s CBD face serum, test subjects reported a 100% overall improvement to the appearance of skin within 14 days. Additional findings from the clinical study include:

  • 85.71% of test subjects noticed an improvement to their skin appearance within the first seven days
  • 80.95% of subjects noticed an improvement to their skin texture within 14 days
  • 80.95% of subjects noticed an improvement in the appearance of fine lines and wrinkles of the mouth area
  • 80.95% of test subjects said they would purchase the Canna serum product if it was made available for sale

InvestmentPitch.com recently recapped this news in a video alert, which can be viewed here: http://www.investmentpitch.com/video/0_vk4mhtrd/Laguna-Blends-CSE-LAG-reported-highlights-of-clinical-data-provided-by-CannaCeuticals

Or on YouTube at the following link: https://www.youtube.com/watch?v=Jzl7yfm2ti0

Laguna Blends also recently announced initial sales of its unique hemp-based Caffe and Pro369 functional beverage products, marketed through its growing network of independent affiliates in the United States and Canada. Unaudited sales for the 11-week period ended May 31, 2016, totaled $105,000, beating internal expectations.

Brand exposure plays a significant role as the Company continues to accelerate its sales strategy. Laguna Blends’ products and operations were recently featured in the June 2016 Canadian Securities Exchange (CSE) quarterly magazine, placing the Company’s profile in financial and

brokerage offices across the country. View the full profile here: http://pr.report/ROcJvkzG

Ray Grimm Jr., president of Laguna Blends, said, “The momentum we have gained in the last 30 days is testament to our commitment to the Laguna Blends brand, our affiliates, and our shareholders. The achievements noted above cast significant light on the high-potential future of Laguna Blends, as well as our ability to rapidly yet successfully execute an aggressive growth strategy. With regard to our negotiations with Canna, we have a lot more potential and milestones on deck, and we look forward to updating our shareholders in the near future.”

Connect with Laguna Blends (CSE:LAG; OTCMKTS:LAGBF; FRA:LB6A) to receive an Investor Presentation.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply